Author:
Zhang Lei,Jiang Hai-yin,Liu Wen-juan
Abstract
ObjectiveThere is growing evidence of a relationship between anti-seizure medication (ASM) use and the risk of dementia. This study examined this association using a meta-analysis approach.MethodsPubMed, EMBASE, and Cochrane Library were systematically searched for peer-reviewed observational studies published up to February 2023. Study quality was evaluated using the Newcastle-Ottawa Scale, and an overall odds ratio (OR) was pooled using fixed or random-effects models.ResultsThe analysis included 9 publications with 10 studies. The results showed that overall ASM exposure was associated with an increased risk of dementia [OR: 1.09, 95% confidence interval (CI): 1.03–1.15; P = 0.003] in general population. However, this association disappeared (OR: 1.02, 95% CI: 0.97–1.07; P = 0.361) when the study data adjusted for drug indications were pooled. Subgroup analysis based on individual drugs found only a positive association among those exposed to valproate, carbamazepine, and clonazepam. Furthermore, an increased risk was found in patients with bipolar disorder exposed to ASMs (OR: 1.43, 95% CI: 1.07–1.92; P = 0.015).ConclusionsThe statistically significant association between ASM and dementia in general population may be driven by unmeasured confounding or several individual first-generation ASMs. However, a higher risk of dementia was observed among bipolar disorder patients treated with ASMs. Given the few included studies and evidence of high heterogeneity, further larger, prospective studies that control for important confounders are needed to verify our findings.
Subject
Neurology (clinical),Neurology
Reference38 articles.
1. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission;Livingston;Lancet.,2020
2. Burden of neurological disorders across the US from 1990–2017: a global burden of disease study;GBD 2017 US Neurological Disorders;JAMA Neurol,2021
3. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019;GBD;Lancet Public Health.,2022
4. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;GBD;Lancet Neurol.,2019
5. Concepts of dementia prevention in the health promotion among older adults: a narrative review;Tsai;Medicine,2022